InSight CEO Appointed to New Jersey Telehealth Review Commission

MARLTON, NJ – InSight Telepsychiatry’s Chief Executive Officer Geoffrey Boyce has been appointed to the New Jersey Telehealth Review Commission. He is one of seven thought leaders asked to sit on the Commission.

The Commission was established as part of the New Jersey telemedicine law that was passed in July of 2017. The law created a seven-member commission that will review information from telemedicine and telehealth organizations and make recommendations for policy and law changes to promote and improve the quality, efficiency and effectiveness of telehealth services in New Jersey.

The NJ Telemedicine bill was signed by Governor Christie on July 21, 2017

Its highlights include:

• It allows New Jersey to join a handful of states that require reimbursement for telemedicine services to the same extent as in-person treatments and consultations.

• It took New Jersey from being one of two states that lacked an official definition of telemedicine, to a state that now defines how telemedicine can and should be safely and appropriately practiced.

• It allows greater access to care for patients previously not covered for telemedicine services. Greater access to care is expected to result in better outcomes for patients with chronic diseases and decrease expenditures over time.

• It allows patients to receive care from the comfort of their own homes when appropriate.

• It removes the requirement for mental health screeners to obtain an unnecessary, special waiver for services provided through telemedicine.

• It allows a large range of providers to practice telemedicine, including: licensed physicians, nurses, nurse practitioners, psychologists, psychiatrists, psychoanalysts, clinical social workers, physician assistants, professional counselors, respiratory therapists, speech pathologists, audiologists and optometrists. This wide range of providers will increase the number of services New Jersey residents can access.

• It involves minimal cost to the state, while providing greater access to care and better outcomes for patients.

“I’m proud of the hard work that was put in to the New Jersey Telemedicine Bill and I believe it truly represents a gold standard for other states,” said Boyce. “This commission will play an important role in ensuring the appropriate growth of telemedicine for increasing access to care across the state. I am honored to be a part of it.”

CEO, Geoffrey Boyce received the Industry Leader Award from the American Telemedicine Association

For the past 10 years, Boyce has advocated for the appropriate use and value of telepsychiatry and has led the development of hundreds of telepsychiatry across the country. In April 2017, he received the Industry Leader Award from the American Telemedicine Association. This annual award is presented to an individual that has made significant contributions to the advancement of telemedicine at federal, state and international levels. He also serves on the advisory board of directors for the Mid-Atlantic Telehealth Resource Center (MATRC).

Now Boyce, along with the other members of the commission, will play a significant role in communicating with telehealth stakeholders on how and where telehealth can be used to increase access to quality care across the state of New Jersey.

About InSight + Regroup 

InSight + Regroup (now Array Behavioral Care) is the leading and largest telepsychiatry service provider in the US with a mission to transform access to quality behavioral health care.  InSight + Regroup serves hundreds of organizations and individuals in various settings across the continuum of care with its on-demand, scheduled services and direct-to-consumer (Inpathy) divisions.  Given its size, diversity of services and extensive experience and expertise, InSight + Regroup is uniquely positioned to enable scalable telepsychiatry programs across the care continuum.  As an industry thought leader, InSight + Regroup has helped shape the field, define the standard of care and advocate for improved telepsychiatry-friendly regulations. To learn more, visit www.arraybc.com.